http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101212032-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-12 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-28 |
| filingDate | 2010-05-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2012-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2012-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101212032-B1 |
| titleOfInvention | Plant stem cells derived from cambium of Asteraceae and its method of isolation |
| abstract | The present invention relates to stem cells derived from the cambium of the family Asteraceae and to a method of isolation culture. The cambium-derived stem cells of the Asteraceae according to the present invention are isolated in an undifferentiated state without dedifferentiation process and are useful because they can be stably maintained in cell growth rate and growth pattern without any change in long-term culture. In addition, the cambium-derived stem cells of the Asteraceae according to the present invention and its culture have the effect of inhibiting NO production that occurs when LPS (Lipopolysaccharide) treatment and the effect of inhibiting gene expression of COX-2 inflammatory cytokines. It can be usefully used as an excellent anti-inflammatory composition. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020117309-A1 |
| priorityDate | 2009-05-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 64.